Socialiya - Entertainment. Knowledge. Community.
CSL slashes revenue projection and takes $5B impairment as interim CEO flags R&D misses, market erosion

CSL has slashed its revenue projection for the fiscal year from $15.8 billion to $15.2 billion and i...

BUSINESS NEWS May 11, 2026

CSL slashes revenue projection and takes $5B impairment as interim CEO flags R&D misses, market erosion

CSL has slashed its revenue projection for the fiscal year from $15.8 billion to $15.2 billion and is taking a $5 billion asset impairment.

7 views 0 likes 0 comments
Share:
CSL has slashed its revenue projection for the fiscal year from $15.8 billion to $15.2 billion and is taking a $5 billion asset impairment.

Author: Fierce Pharma

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya